Nitric oxide synthase inhibitors attenuate the neuronal injury response in cerebral cortex.
Gardiner
I M
IM
Department of Biochemistry, Charing Cross and Westminster Medical School, London, U.K.
Adams
J
J
Castell
F
F
de Belleroche
J S
JS
D000594:Amino Acid Oxidoreductases / Q000037:antagonists & inhibitors*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D002540:Cerebral Cortex / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D004790:Enzyme Induction; D007608:Kainic Acid / Q000037:antagonists & inhibitors; D019331:NG-Nitroarginine Methyl Ester; D009474:Neurons / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D009498:Neurotoxins / Q000037:antagonists & inhibitors; D019001:Nitric Oxide Synthase; D019335:Nitroarginine; D009955:Ornithine Decarboxylase / Q000096:biosynthesis; D065108:Ornithine Decarboxylase Inhibitors
D009498:Neurotoxins; D065108:Ornithine Decarboxylase Inhibitors; D019335:Nitroarginine; D001120:Arginine; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases; D009955:Ornithine Decarboxylase; D007608:Kainic Acid; D019331:NG-Nitroarginine Methyl Ester